Rare diseases

News

Akari soars ahead of read-out for Soliris rival

Investors are anticipating good news from a potential rival to Alexion’s rare disease blockbuster Soliris, with shares in the company behind it soaring.

News

J&J says $30bn Actelion buy on track

Deal set to close in Q2.

News

Charities unite to oppose NICE rare disease rules

MPs to discuss controversial plan in special debate.

News

FDA fast tracks Shire clotting disease drug

The US regulator has given a Fast Track designation to a Shire pipeline drug for a life-threatening blood clotting disease, hereditary thrombotic thrombocytopenic purpura.

Views & Analysis